Atorvastatin attenuates TNF-α-induced increase of glucose oxidation through PGC-1α upregulation in cardiomyocytes

Journal of Cardiovascular Pharmacology

Volumn 59, Issue 6, 2012, Pages 500-506

  Gao, Feng ^a   Ni, Yinxing ^b   Luo, Zhidan ^b   Liang, Yi ^b   Yan, Zhencheng ^b   Xu, Xingsen ^b   Liu, Daoyan ^b   Wang, Jiang ^a   Zhu, Shanjun ^a   Zhu, Zhiming ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

atorvastatin; glucose oxidation; PGC 1 ; TNF

Indexed keywords

ATORVASTATIN; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITYL TRANSFERASE 1; FARNESOL; GERANYLGERANIOL; MEVALONIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PYRUVATE DEHYDROGENASE KINASE 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE SILENCING; GLUCOSE OXIDATION; HEART MUSCLE CELL; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; CELL LINE; DOWN-REGULATION; GLUCOSE; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; PROTEIN KINASES; PYRROLES; RATS; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84862226119     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31824c853c     Document Type: Article

References (34)

1. Finck BN, Kelly DP. Peroxisome proliferator-Activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation. 2007;115:2540-2548.
2. Lopaschuk GD, Jaswal JS. Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J Cardiovasc Pharmacol. 2010;56:130-140.
3. Taegtmeyer H. Switching metabolic genes to build a better heart. Circulation. 2002;106:2043-2045.
4. Jobe LJ, Melendez GC, Levick SP, et al. TNF-Alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload. Am J Physiol Heart Circ Physiol. 2009;297:H1462-H1468.
5. Palomer X, Alvarez-Guardia D, Rodriguez-Calvo R, et al. TNF-Alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc Res. 2009;81:703-712.
6. Alvarez-Guardia D, Palomer X, Coll T, et al. The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. Cardiovasc Res. 2010;87:449-458.
7. Tawfik MK, Ghattas MH, Abo-Elmatty DM, et al. Atorvastatin restores the balance between pro-inflammatory and anti-inflammatory mediators in rats with acute myocardial infarction. Eur Rev Med Pharmacol Sci. 2010;14:499-506.
8. Furuya DT, Poletto AC, Favaro RR, et al. Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamatetreated obese mice. Metabolism. 2010;59:395-399.
9. Scarpulla RC. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta. 2011;1813: 1269-1278.
10. Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis: The central role of PGC-1alpha. Cardiovasc Res. 2008;79:208-217.
11. Philp A, BelewMY, Evans A, et al. The PGC-1{alpha} related co-Activator (PRC) promotes mitochondrial and myogenic adaptations in C2C12 myotubes. Am J Physiol Regul Integr Comp Physiol. 2011;301:864-872.
12. Kolwicz SC Jr, Tian R. Glucose metabolism and cardiac hypertrophy. Cardiovasc Res. 2011;90:194-201.
13. Arany Z, Novikov M, Chin S, et al. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci U S A. 2006;103:10086-10091.
14. Wang W, Wong CW. Statins enhance peroxisome proliferator-Activated receptor gamma coactivator-1alpha activity to regulate energy metabolism. J Mol Med (Berl). 2010;88:309-317.
15. Zhang J, Zou L, Liu Q, et al. Rapid generation of dendritic cell specific transgenic mice by lentiviral vectors. Transgenic Res. 2009;18:921-931.
16. Chen Y, Ye J, Cao L, et al. Myostatin regulates glucose metabolism via the AMP-Activated protein kinase pathway in skeletal muscle cells. Int J Biochem Cell Biol. 2010;42:2072-2081.
17. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991;19:2499.
18. Bagattin A, Hugendubler L, Mueller E. Transcriptional coactivator PGC-1alpha promotes peroxisomal remodeling and biogenesis. Proc Natl Acad Sci U S A. 2010;107:20376-20381.
19. Liang H, Ward WF. PGC-1alpha: A key regulator of energy metabolism. Adv Physiol Educ. 2006;30:145-151.
20. Takemoto M, Node K, Nakagami H, et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest. 2001;108: 1429-1437.
21. Planavila A, Laguna JC, Vazquez-Carrera M. Atorvastatin improves peroxisome proliferator-Activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation. Biochim Biophys Acta. 2005;1687:76-83.
22. Rowe GC, Jiang A, Arany Z. PGC-1 coactivators in cardiac development and disease. Circ Res. 2010;107:825-838.
23. Lionetti V, Stanley WC, Recchia FA. Modulating fatty acid oxidation in heart failure. Cardiovasc Res. 2011;90:202-209.
24. Jaswal JS, Keung W, Wang W, et al. Targeting fatty acid and carbohydrate oxidation-A novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta. 2011;1813:1333-1350.
25. Neubauer S. The failing heart-An engine out of fuel. N Engl J Med. 2007;356:1140-1151.
26. Schilling J, Kelly DP. The PGC-1 cascade as a therapeutic target for heart failure. J Mol Cell Cardiol. 2011;51:578-583.
27. Connaughton S, Chowdhury F, Attia RR, et al. Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin. Mol Cell Endocrinol. 2010;315:159-167.
28. Blanco-Colio LM, Villa A, Ortego M, et al. 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of bcl-2 expression and rho a prenylation. Atherosclerosis. 2002;161:17-26.
29. Staines AG, Sindelar P, Coughtrie MW, et al. Farnesol is glucuronidated in human liver, kidney and intestine in vitro, and is a novel substrate for ugt2b7 and ugt1a1. Biochem J. 2004;384:637-645.
30. Bellosta S, Ferri N, Arnaboldi L, et al. Pleiotropic effects of statins in atherosclerosis and diabetes. Diabetes Care. 2000;23(suppl 2): B72-B78.
31. Kunitomo M, Yamaguchi Y, Kagota S, et al. Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome. J Pharmacol Sci. 2008;107:128-137.
32. Wende AR, Huss JM, Schaeffer PJ, et al. PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: A mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol. 2005;25:10684-10694.
33. Kleiner S, Nguyen-Tran V, Bare O, et al. PPAR{delta} agonism activates fatty acid oxidation via PGC-1{alpha} but does not increase mitochondrial gene expression and function. J Biol Chem. 2009;284:18624-18633.
34. Michael LF, Wu Z, Cheatham RB, et al. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc Natl Acad Sci U S A. 2001;98: 3820-3825.